Sign in
bf/NASDAQ:KTTA_icon.jpeg

NASDAQ:KTTA

Pasithea Therapeutics Corp.

  • Stock

USD

Last Close

4.56

26/07 20:00

Market Cap

5.45M

Beta: -

Volume Today

2.75K

Avg: 58.36K

PE Ratio

−0.56

PFCF: −0.43

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
0.50
-
average payables
807.17K
-
average receivables
151.07K
-
151.07K
0%
book value per share
4.94
-
1.68
65.95%
19.08
1,033.46%
capex per share
-0.00
-
-0.08
3,997.97%
-0.03
66.98%
capex to depreciation
-15.59
-
-66.06
323.64%
-0.05
99.92%
capex to operating cash flow
0.01
-
0.15
2,067.84%
0.00
98.26%
capex to revenue
-1.43
-
-4.40
207.88%
cash per share
5.09
-
1.31
74.21%
13.31
914.28%
days of inventory on hand
days payables outstanding
days sales outstanding
226.65
-
debt to assets
0.02
-
0.00
84.76%
debt to equity
0.02
-
0.00
83.99%
dividend yield
earnings yield
-0.12
-
-0.81
582.24%
-1.76
118.35%
enterprise value
-243.65K
-
-34.55M
14,080.36%
-16.01M
53.67%
-7.17M
55.20%
enterprise value over ebitda
7.67
-
1.09
85.84%
0.47
56.92%
ev to operating cash flow
10.89
-
1.10
89.90%
0.53
51.40%
ev to sales
-2.29K
-
-32.90
98.57%
free cash flow per share
-0.31
-
-0.66
115.34%
-10.97
1,559.18%
free cash flow yield
-0.17
-
-1.03
493.69%
-1.48
43.95%
graham net net
4.91
-
1.22
75.24%
11.10
813.08%
graham number
4.82
-
4.42
8.20%
74.73
1,588.97%
income quality
1.46
-
1.04
28.45%
0.87
17.15%
intangibles to total assets
0
-
0
0.22
Infinity%
352.42
161,548.07%
interest coverage
-8.87K
-
-145.26K
1,537.11%
interest debt per share
0.00
-
0.04
75,087.82%
0.07
81.40%
inventory turnover
invested capital
0.02
-
0.00
83.99%
market cap
18.42M
-
16.21M
11.97%
9.08M
44.01%
net current asset value
241.35K
-
51.40M
21,196.59%
31.39M
38.92%
13.97M
55.49%
net debt to ebitda
11.75
-
2.19
81.40%
1.06
51.51%
net income per share
-0.21
-
-0.52
147.46%
-13.01
2,416.75%
operating cash flow per share
-0.31
-
-0.58
89.03%
-10.95
1,798.01%
payables turnover
receivables turnover
1.61
-
research and ddevelopement to revenue
5.48
-
return on tangible assets
-0.04
-
-0.37
806.39%
0.00
100.47%
revenue per share
0.00
-
0.02
1,231.04%
roe
-0.04
-
-0.31
626.65%
-0.68
122.04%
roic
-0.09
-
-0.31
256.95%
-4.60
1,369.66%
sales general and administrative to revenue
shareholders equity per share
4.94
-
1.68
65.95%
19.08
1,033.46%
stock based compensation to revenue
31.29
-
1.14
96.37%
tangible asset value
241.35K
-
51.42M
21,204.92%
32.65M
36.51%
-9.18B
28,220.56%
tangible book value per share
4.94
-
1.29
73.84%
-6.46K
499,456.69%
working capital
241.35K
-
52.85M
21,798.52%
32.20M
39.08%
14.06M
56.34%

All numbers in USD (except ratios and percentages)